| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |